Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitamin D: What's the Proper Dose?

Journal of the American Geriatrics Society·2026
Same author

Differential Prescribing of Antimuscarinic Agents in Older Adults with Cognitive Impairment.

Drugs & aging·2018
Same author

A Community-Based Collaborative Care Model to Improve Functional Health in Underserved Community-Dwelling Older Adults.

Journal of aging and health·2017
Same author

Cognitive Dysfunction, Medication Management, and the Risk of Readmission in Hospital Inpatients.

Journal of the American Geriatrics Society·2016
Same author

Statins for the primary prevention of cardiovascular disease in women?

Menopause (New York, N.Y.)·2012
Same author

Bone density: a surrogate for estrogen exposure or a systemic inflammatory disorder?

Menopause (New York, N.Y.)·2012

Related Experiment Video

Updated: Jul 3, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Hormone therapy and stroke.

Stanley J Birge1

  • 1Division of Geriatrics and Nutritional Science, Washington University School of Medicine, St Louis, Missouri 63108, USA. SBirge@DOM.wustl.edu

Clinical Obstetrics and Gynecology
|August 5, 2008
PubMed
Summary
This summary is machine-generated.

Low-dose or transdermal hormone therapy effectively manages menopausal symptoms with no increased risk of cardiovascular disease, stroke, venous thrombotic disease, or breast cancer. These benefits persist with continued therapy.

Related Experiment Videos

Last Updated: Jul 3, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Area of Science:

  • Reproductive Endocrinology
  • Cardiovascular Health
  • Oncology

Background:

  • Menopausal symptoms significantly impact women's quality of life.
  • Hormone therapy (HT) is a common treatment, but safety concerns persist.
  • Optimal HT formulations and dosages require ongoing investigation.

Purpose of the Study:

  • To evaluate the safety and efficacy of low-dose or transdermal hormone therapy for menopausal symptom management.
  • To assess the risk of cardiovascular disease, stroke, venous thrombotic disease, and breast cancer associated with these HT regimens.
  • To determine if favorable outcomes persist with continued therapy.

Main Methods:

  • Review of available biochemical and clinical data.
  • Analysis of patient outcomes related to low-dose and transdermal hormone therapy initiation and continuation.
  • Comparative risk assessment for major adverse events.

Main Results:

  • Biochemical and clinical data strongly support low-dose or transdermal HT for menopausal symptom management.
  • No increased risk of cardiovascular disease, stroke, venous thrombotic disease, or breast cancer was observed.
  • Favorable effects on these outcomes were noted and persisted with ongoing therapy.

Conclusions:

  • Low-dose or transdermal hormone therapy is recommended for managing menopausal symptoms when feasible.
  • These HT regimens demonstrate a favorable safety profile regarding major cardiovascular and oncologic events.
  • Continuation of therapy sustains the observed benefits, supporting long-term use.